A thrombophilia status would be complementary to the risk score approach described here, as a functional test in the presence of clinical suscpiscion, in order to take into account rare mutations such as the one present in Protein S, Protein C or Antithrombin genes. This evidence concerns the gene PROS1 and thrombophilia.